Portside Wealth Group, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1978608 Provo, UT

Position in REGN

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$1,346,222

-$182,059 QoQ

Shares Held

2,159

+9.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

#595

of 1,322 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Portside Wealth Group, LLC holds $8,173,581 across 8 Biotechnology names. REGN ranks #3 (16.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	5,258	$2,611,805
2	LGND	Ligand Pharmaceuticals Inc	4,810	$1,520,392
3	REGN	Regeneron Pharmaceuticals, Inc. This page	2,159	$1,346,222
4	TGTX	Tg Therapeutics, Inc.	16,458	$904,202
5	HALO	Halozyme Therapeutics, Inc.	8,505	$665,685
6	VCEL	Vericel Corp	14,742	$655,871
7	KRYS	Krystal Biotech, Inc.	679	$252,363
8	ALNY	Alnylam Pharmaceuticals, Inc.	721	$217,041

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,346,222	2,159	+9.2%	Shares	Sole	2026-07-14
2026-03-31	$1,528,281	1,978	+10.8%	Shares	Sole	2026-05-12
2025-12-31	$1,378,559	1,786	+15.4%	Shares	Sole	2026-01-21
2025-09-30	$869,831	1,547	+17.0%	Shares	Sole	2025-11-05
2025-06-30	$694,050	1,322	+18.7%	Shares	Other	2025-08-11
2025-03-31	$706,532	1,114	+43.6%	Shares	Other	2025-04-14
2024-12-31	$552,768	776	+7.2%	Shares	Other	2025-04-14
2024-09-30	$761,096	724	+14.7%	Shares	Other	2024-10-31
2024-06-30	$663,199	631	+5.3%	Shares	Other	2024-07-18
2024-03-31	$576,531	599	+9.7%	Shares	Other	2024-04-17
2023-12-31	$479,546	546	+11.9%	Shares	Other	2024-01-16
2023-09-30	$401,604	488	+22.6%	Shares	Other	2023-10-27
2023-06-30	$285,978	398	—	Shares	Other	2023-09-01
No filing history on record for this holder in this stock.